Related Experiment Video
Updated: Feb 2, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.5K
Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
1Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Frontiers in Cellular and Infection Microbiology
|November 22, 2018
Summary
Interleukin-13 (IL-13) plays a role in ulcerative colitis inflammation. Targeting IL-13 signaling independently of the IL-4 receptor-alpha (IL-4Rα) may offer new therapeutic strategies for ulcerative colitis.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Interleukin-13 (IL-13) is implicated in ulcerative colitis (UC) pathogenesis and inflammation.
- IL-13 targeting has been explored as a therapeutic strategy for UC.
Purpose of the Study:
- To review the role of IL-13 in UC.
- To discuss current IL-13 targeted therapies for UC.
- To highlight IL-13 signaling pathways independent of IL-4 receptor-alpha (IL-4Rα).
Main Methods:
- Literature review of studies on IL-13 in ulcerative colitis.
- Analysis of clinical trial data regarding IL-4Rα blockade in UC patients.
Main Results:
- Evidence suggests IL-13 contributes to UC pathology and inflammation.
- Blocking IL-4Rα has shown insufficient efficacy in UC patients.
- IL-13 may mediate UC through pathways independent of IL-4Rα.
Conclusions:
- The role of IL-13 in UC requires further investigation.
- Targeting IL-13 signaling independently of IL-4Rα presents a potential therapeutic avenue for UC.
- Future UC treatments should consider alternative IL-13 signaling mechanisms.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
517
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
517
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
995
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
995
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.3K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
01:10Carbon-13 (¹³C) NMR: Overview
7.7K
Carbon-13 is a naturally occurring NMR-active isotope of carbon with a low natural abundance of 1.1%. In contrast, carbon-12 is the most abundant isotope of carbon with zero nuclear spin. Therefore, it is NMR inactive. The gyromagnetic ratio of carbon-13 is smaller than that of protons. As a result, carbon-13 resonance is about 6000 times weaker than proton resonance. For a given magnetic field strength, the resonance frequency of carbon-13 is about one-fourth of the resonance frequency for...
7.7K
01:28Peptic Ulcer Disease II: Pathophysiology
2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K